Suppliers / Aurobindo Pharma Limited, Unit - VIII

Aurobindo Pharma Limited, Unit - VIII

India Updated 9 July 2026

Aurobindo Pharma Limited, Unit - VIII is an API manufacturer based in India.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Amlodipine SFDA (Saudi Arabia) 1
Bosentan SFDA (Saudi Arabia) 1
Carvedilol SFDA (Saudi Arabia) 1
Dutasteride SFDA (Saudi Arabia) 1
Febuxostat SFDA (Saudi Arabia) 1
Fluconazole SFDA (Saudi Arabia) 1
Moxifloxacin SFDA (Saudi Arabia) 1
Palonosetron SFDA (Saudi Arabia) 1
Ramipril SFDA (Saudi Arabia) 1
Tamsulosin SFDA (Saudi Arabia) 1
Show all 11 molecules on file
Torasemide SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Questions about Aurobindo Pharma Limited, Unit - VIII

What does Aurobindo Pharma Limited, Unit - VIII make?
11 molecules are on record against Aurobindo Pharma Limited, Unit - VIII, including Amlodipine, Bosentan, Carvedilol and Dutasteride. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Aurobindo Pharma Limited, Unit - VIII?

Ask Fred what the record holds on Aurobindo Pharma Limited, Unit - VIII, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability